Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.

Biotechnology

Amunix

Amunix's headquarters in South San Francisco, CA, United States

Paul Hudson

Mika Derynck

Bryan Irving

Volker Schellenberger

Mika Kakefuda Derynck

The Laboratory and Research team at Amunix is focused on conducting cutting-edge biopharmaceutical research and development. The team designs and develops novel biologics, protein, and peptide therapeutics, employing a variety of analytical and bioanalytical techniques. Members of this multidisciplinary team collaborate to perform in vivo and in vitro experiments, protein analytics, purification processes, and mass spectrometry, all aimed at discovering and optimizing new therapeutic candidates.

Laboratory and Research

The Project and Program Management team at Amunix orchestrates the planning, execution, and oversight of the company's biopharmaceutical development initiatives. This includes managing timelines, resources, and cross-functional collaboration to ensure successful discovery, design, and development of novel biologics, proteins, and peptide therapeutics. Their strategic leadership and project management expertise drive the alignment of Amunix’s research and development objectives with its overall business goals.

Project and Program Management

The Leadership Team at Amunix is responsible for setting the strategic direction and vision of the company, guiding the development of innovative biologics and therapeutics. They oversee core functions including scientific research, technical operations, and medical strategy, ensuring that project goals align with organizational priorities and regulatory standards. By leveraging their diverse expertise, the team drives collaboration and decision-making to advance Amunix's mission of delivering breakthrough therapies.

Leadership Team

The Clinical and Regulatory Affairs team at Amunix is responsible for overseeing the design, execution, and management of clinical trials, ensuring that all clinical data is accurately collected and managed, and maintaining compliance with Good Clinical Practice (GCP) standards. Additionally, the team navigates the regulatory landscape to secure and maintain approvals from health authorities, particularly focusing on oncology therapeutics, to bring novel biologics, proteins, and peptides to market.

Clinical and Regulatory Affairs

The Bioanalytical Sciences Team at Amunix is responsible for developing and implementing analytical methods to evaluate and quantify biologics, proteins, and peptide therapeutics throughout the drug development process. Their work ensures the safety, efficacy, and quality of Amunix's novel therapeutic candidates.

Bioanalytical Sciences Team

The Drug Development and Protein Sciences team at Amunix focuses on the discovery and engineering of novel biologics, proteins, and peptide therapeutics. This team is responsible for advancing formulation and drug product development, as well as overseeing the protein engineering processes to ensure the creation of innovative and effective medical treatments.

Amunix

Org chart

Teams

Laboratory and Research

Project and Program Management

Leadership Team

Clinical and Regulatory Affairs

Bioanalytical Sciences Team

Drug Development and Protein Sciences

Offices

Amunix

Org chart

Teams

Laboratory and Research

Project and Program Management

Leadership Team

Clinical and Regulatory Affairs

Bioanalytical Sciences Team

Drug Development and Protein Sciences

Offices

Related companies